Efficient plasmid-mediated gene transfection of ovine bone marrow mesenchymal stromal cells

Cytotherapy

Volumn 15, Issue 2, 2013, Pages 163-170

  Locatelli, Paola ^a   Olea, Fernanda Daniela ^a   Hnatiuk, Anna ^a   Sepúlveda, Diana ^a   Sáez, Juan Manuel Pérez ^b   Argüello, Rafael ^a   Crottogini, Alberto ^a  

^a FAVALORO UNIVERSITY   (Argentina)

^b Bio Sidus   (Argentina)

Author keywords

Mesenchymal stromal cell; Plasmids; Sheep; Transfection efficiency; VEGF

Indexed keywords

GREEN FLUORESCENT PROTEIN; LIPOFECTAMINE; REAGENT; VASCULOTROPIN; VIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; BONE MARROW MESENCHYMAL STROMAL CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL VIABILITY; CONTROLLED STUDY; EX VIVO STUDY; FLOW CYTOMETRY; GENETIC CODE; GENETIC TRANSFECTION; IMMUNITY; MESENCHYMAL STROMA CELL; NONHUMAN; PARACRINE SIGNALING; PLASMID; PRIORITY JOURNAL; SUPERNATANT; TRANSGENE;

EID: 84875480639     PISSN: 14653249     EISSN: 14772566     Source Type: Journal    
DOI: 10.1016/j.jcyt.2012.11.004     Document Type: Article

References (27)

1. Kinnaird T, Stabile E, Burnett MS, Shou M, Lee CW, Barr S, et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation. 2004;109:1543-9.
2. Gnecchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, et al. Evidence supporting paracrine hypothesis for Aktmodified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006;20:661-9.
3. Song H, Song BW, Cha MJ, Choi IG, Hwang KC. Modification of mesenchymal stem cells for cardiac regeneration. Expert Opin Biol Ther. 2010;10:309-19.
4. Dixon JA, Spinale FG. Large animal models of heart failure: a critical link in the translation of basic science to clinical practice. Circ Heart Fail. 2009;2:262-71.
5. Locatelli P, Olea FD, Mendiz O, Salmo F, Fazzi L, Hnatiuk A, et al. An ovine model of postinfarction dilated cardiomyopathy in animals with highly variable coronary anatomy. ILAR J. 2011;52:-16-21.
6. Markovitz LJ, Savage EB, Ratcliffe MB, Bavaria JE, Kreiner G, Iozzo RV, et al. Large animal model of left ventricular aneurysm. Ann Thorac Surg. 1989;48:838-45.
7. Vera Janavel G, Crottogini A, Cabeza Meckert P, Cuniberti L, Mele A, Papouchado M, et al. Plasmid-mediated VEGF gene transfer induces cardiomyogenesis and reduces myocardial infarct size in sheep. Gene Ther. 2006;13:1133-42.
8. Locatelli P, Olea FD, De Lorenzi A, Salmo F, Vera Janavel GL, Hnatiuk AP, et al. Reference values for echocardiographic parameters and indexes of left ventricular function in healthy, young adult sheep used in translational research: comparison with standardized values in humans. Int J Clin Exp Med. 2011;4:258-64.
9. Markel TA, Wang Y, Herrmann JL, Crisostomo PR, Wang M, Novotny NM, et al. VEGF is critical for stem cellmediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function. Am J Physiol Heart Circ Physiol. 2008;295: H2308-14.
10. Madeira C, Mendes RD, Ribeiro SC, Boura JS, Aires- Barros MR, da Silva CL, et al. Nonviral gene delivery to mesenchymal stem cells using cationic liposomes for gene and cell therapy. J Biomed Biotechnol. 2010;2010:735349.
11. Biswas J, Mishra SK, Kondaiah P, Bhattacharya S. Syntheses, transfection efficacy and cell toxicity properties of novel cholesterol-based gemini lipids having hydroxyethyl head group. Org Biomol Chem. 2011;9:4600-13.
12. Bakhshandeh B, Soleimani M, Hafizi M, Ghaemi N. A comparative study on nonviral genetic modifications in cord blood and bone marrow mesenchymal stem cells. Cytotechnology. 2012;64:523-40.
13. Conget PA, Minguell JJ. Adenoviral-mediated gene transfer into ex vivo expanded human bone marrow mesenchymal progenitor cells. Exp Hematol. 2000;28:382-90.
14. Reiser J, Zhang XY, Hemenway CS, Mondal D, Pradhan L, La Russa VF. Potential of mesenchymal stem cells in gene therapy approaches for inherited and acquired diseases. Expert Opin Biol Ther. 2005;5:1571-84.
15. Gheisari Y, Soleimani M, Azadmanesh K, Zeinali S. Multipotent mesenchymal stromal cells: optimization and comparison of five cationic polymer-based gene delivery methods. Cytotherapy. 2008;10:815-23.
16. Hoelters J, Ciccarella M, Drechsel M, Geissler C, Gülkan H, Böcker W, et al. Nonviral genetic modification mediates effective transgene expression and functional RNA interference in human mesenchymal stem cells. J Gene Med. 2005;7: 718-28.
17. Gounis MJ, Spiga MG, Graham RM, Wilson A, Haliko S, Lieber BB, et al. Angiogenesis is confined to the transient period of VEGF expression that follows adenoviral gene delivery to ischemic muscle. Gene Ther. 2005;12:762-71.
18. Tang K, Breen EC, Gerber HP, Ferrara NM, Wagner PD. Capillary regression in vascular endothelial growth factordeficient skeletal muscle. Physiol Genomics. 2004;18: 63-9.
19. Crottogini A, Meckert PC, Vera Janavel G, Lascano E, Negroni J, Del Valle H, et al. Arteriogenesis induced by intramyocardial vascular endothelial growth factor 165 gene transfer in chronically ischemic pigs. Hum Gene Ther. 2003; 14:1307-18.
20. Laguens R, Cabeza Meckert P, Vera Janavel G, De Lorenzi A, Lascano E, Negroni J, et al. Cardiomyocyte hyperplasia after plasmid-mediated vascular endothelial growth factor gene transfer in pigs with chronic myocardial ischemia. J Gene Med. 2004;6:222-7.
21. Matsumoto R, Omura T, Yoshiyama M, Hayashi T, Inamoto S, Koh KR, et al. Vascular endothelial growth factor- expressing mesenchymal stem cell transplantation for the treatment of acute myocardial infarction. Arterioscler Thromb Vasc Biol. 2005;25:1168-73.
22. Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, et al. Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology. 2007;107:17-29.
23. Gao F, He T, Wang H, Yu S, Yi D, Liu W, et al. A promising strategy for the treatment of ischemic heart disease: Mesenchymal stem cell-mediated vascular endothelial growth factor gene transfer in rats. Can J Cardiol. 2007;23:891-8.
24. Olea FD, Vera Janavel G, Cuniberti L, Yannarelli G, Cabeza Meckert P, Cors J, et al. Repeated, but not single, VEGF gene transfer affords protection against ischemic muscle lesions in rabbits with hindlimb ischemia. Gene Ther. 2009;16:716-23.
25. Laguens RP, Crottogini AJ. Cardiac regeneration: the gene therapy approach. Expert Opin Biol Ther. 2009;9:411-25.
26. Gräbner W, Pfitzer P. Number of nuclei in isolated myocardial cells of pigs. Virchows Arch B Cell Pathol. 1974;15:279-94.
27. Adler CP, Friedburg H, Herget GW, Neuburger M, Schwalb H. Variability of cardiomyocyte DNA content, ploidy level and nuclear number in mammalian hearts. Virchows Arch. 1996;429:159-64.